Virological failure and development of new resistance mutations according to <scp>CD</scp>4 count at combination antiretroviral therapy initiation
Sophie José(NHS England), Sarah Fidler(NIHR Imperial Biomedical Research Centre), David Dunn(Indiana University – Purdue University Indianapolis), Alison Cox, Killian Quinn(Imperial College London), Caroline Sabin(Primary Health Care)
Cited by 7
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930